Unicycive Therapeutics, Inc.
UNCY
$5.09
$0.061.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.43M | 54.59M | 41.27M | 42.70M | 22.33M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.63M | 7.87M | 6.52M | 6.71M | 6.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.27M | 1.09M | 1.17M | 881.00K | 840.00K |
| Total Current Assets | 71.32M | 63.55M | 48.96M | 50.29M | 29.53M |
|
|
|||||
| Total Current Assets | 71.32M | 63.55M | 48.96M | 50.29M | 29.53M |
| Net Property, Plant & Equipment | 709.00K | 861.00K | 174.00K | 324.00K | 469.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 72.03M | 64.41M | 49.14M | 50.61M | 30.00M |
|
|
|||||
| Total Accounts Payable | 2.23M | 1.14M | 383.00K | 957.00K | 775.00K |
| Total Accrued Expenses | 2.14M | 3.05M | 1.52M | 2.76M | 2.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 616.00K | 598.00K | 117.00K | 265.00K | 409.00K |
| Total Finance Division Other Current Liabilities | 13.72M | 21.70M | 16.92M | 9.15M | 10.21M |
| Total Other Current Liabilities | 13.72M | 21.70M | 16.92M | 9.15M | 10.21M |
| Total Current Liabilities | 18.70M | 26.49M | 18.94M | 13.13M | 13.57M |
|
|
|||||
| Total Current Liabilities | 18.70M | 26.49M | 18.94M | 13.13M | 13.57M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 55.00K | 217.00K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.76M | 26.70M | 18.94M | 13.13M | 13.57M |
|
|
|||||
| Common Stock & APIC | 195.66M | 178.35M | 158.02M | 150.64M | 123.58M |
| Retained Earnings | -142.37M | -140.65M | -127.83M | -113.16M | -107.15M |
| Treasury Stock & Other | -23.00K | 6.00K | -1.00K | -- | -- |
| Total Common Equity | 53.27M | 37.70M | 30.20M | 37.48M | 16.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 53.27M | 37.70M | 30.20M | 37.48M | 16.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 53.27M | 37.70M | 30.20M | 37.48M | 16.43M |
|
|
|||||